Steven Quay, MD, PhD

Dr. Steven Quay is a physician-scientist, entrepreneur, and recognized authority on the convergence ofbiotechnology and artificial intelligence. He is the founder and CEO of Atossa Therapeutics, Inc. (Nasdaq:ATOS), developing novel treatments for the prevention and treatment of breast cancer. In 2025, he wasappointed Senior Fellow at the Hudson Institute, where he leads policy research on the national securityrisks of AI-enabled biotechnology.Dr. Quay earned his M.D., Ph.D., and M.S. from the University of Michigan, trained at MIT with NobelLaureate H. Gobind Khorana, completed residency at Harvard–Massachusetts General Hospital, and servedon the faculties of Harvard Medical School and Stanford University.He has authored 400 scientific publications and been cited over 12,300 times, ranking him in the top 1% ofscientists worldwide. His inventions include seven FDA-approved medicines that have helped over 80million patients, supported by 95 U.S. patents and more than 1,000 global filings. He is a two-time Ernst &Young Entrepreneur of the Year.Dr. Quay has written two Amazon bestsellers on COVID-19, contributed Wall Street Journal op-eds, andtestified before the U.S. Congress. His TEDx talk on breast cancer prevention has been viewed more than229,000 times.